An International Journal Clinical Rhinology

Register      Login

VOLUME 5 , ISSUE 3 ( September-December, 2012 ) > List of Articles

RESEARCH ARTICLE

To Study the Utilization Pattern of Nasal Decongestants and their Effects on Heart Rate and Blood Pressure

Asmita Chopra

Keywords : Nasal decongestants,Xylometazoline,Pseudoephedrine,Allergic rhinitis

Citation Information : Chopra A. To Study the Utilization Pattern of Nasal Decongestants and their Effects on Heart Rate and Blood Pressure. Clin Rhinol An Int J 2012; 5 (3):91-94.

DOI: 10.5005/jp-journals-10013-1126

Published Online: 01-12-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background

Nasal decongestants (NDs) are frequently prescribed over the counter (OTC) drugs for cough and cold. These are sympathomimetic drugs, which act through α1 and β1 adrenoceptors to cause vasoconstriction and positive inotropic, chronotropic and dromotropic effect on the heart. This study was conducted to assess the pattern of utilization of the NDs and their effect on heart rate (HR) and blood pressure (BP). Patients were observed for any other adverse drug reactions (ADRs).

Materials and methods

Randomly 100 prescriptions containing NDs were collected from the otorhinolaryngology OPD and were analyzed. All these patients were examined for HR and BP on day 0, 3 and 7 of administration of NDs. Any ADRs were also recorded.

Results

Mean ND used per patient was 1.08/patient. Commonly prescribed NDs were phenylephrine (72.2%), pseudoephedrine (12.9%), phenylpropanolamine (6.5%), xylometazoline (6.5%) and oxymetazoline (1.8%). Eight patients received two NDs orally and/or topically. There was a significant rise in heart rate on day 7 (p < 0.05). However, the rise in BP was insignificant both on days 3 and 7. Frequently observed ADR's included headache, palpitations and dizziness.

Discussion

Some NDs are known to raise the HR and BP. Baseline BP monitoring should be done to avoid any further rise in BP and HR. being an OTC drug there are more chances of adverse effects of these NDs. It is suggested that NDs should be prescription only drugs, till adequate evidence is available regarding their safety.

How to cite this article

Rehan HS, Chopra A, Kumar S. To Study the Utilization Pattern of Nasal Decongestants and their Effects on Heart Rate and Blood Pressure. Clin Rhinol An Int J 2012;5(3):91-94.


PDF Share
  1. Adrenergic agonists and antagonists in Goodman and Gilman's the pharmacological basis of therapeutics (11th ed). In: Brunton LL, Lazo JS, Parker KL (Eds). McGraw-Hill Medical Publishing Division, New York 2006;237-95.
  2. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000;343:1826-32.
  3. Hemorrhagic Stroke Project. Food and Drug Administration 2000.
  4. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
  5. Pattern of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons; Results of Kuopio 75+ study: A cross section analysis. Drugs Aging 2009;26(6):493-503.
  6. A study on the drug prescribing pattern and use of antimicrobial agents at a tertiary care teaching hospital in Eastern Nepal. Ind J Pharmacol 1998;30(3):175-80.
  7. Field tests for rational drug use in twelve developing countries. Lancet 1993;342:1408-10.
  8. Prescribing practices in two health care facilities in Warri, South Nigeria: A comparative study. Trop J Pharm Res 2003;2(1):175-82.
  9. Study of drug utilization pattern in dental OPD at tertiary care teaching hospital. IJDR 2001;12:51-56.
  10. Essential drugs: WHO Model List, WHO Drug Information, (15th ed). WHO: 2007.
  11. Promoting rational prescribing: An international perspective. Br J Clin Pharma 1995;39(1):1-6.
  12. Irrational drug use in India: A prescription survey from Goa. J Postgrad Med 2005,51(1);9-12.
  13. Inhibition of NOS by nasal decongestants. Eur Resp J 2000;16:437-44.
  14. Efficacy and safety of oral phenylepherine: Systematic review and meta-analysis. Ann Phamacother 2007;41(3):381-90.
  15. Dose response study of nasal decongestant and cardiovascular effects of pseudoephedrine. Br J Clin Pharmac 1980;9(4):351-58.
  16. Histamine challenge and anterior nasal rhinometry: Use in assessment of pseudoephedrine. Br J Clin Pharmac 1978;6:51-58.
  17. Phenylpropanolamine induced intraventricular hemorrhage. Neurol India 2003 Mar;51(1):117-18.
  18. Stroke associated with sympathomimetics contained in OTC cough and cold preparations. Stroke 2003;34:1667-72.
  19. Phenylpropanolamine and blood pressure. Am J Clin Nutr 1992;55:206s-10s.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.